In the beginning, there was the Human Genome Project. For all its epochal significance, it was little more than that: a beginning. It delivered the first 3.5 billion base-pair DNA sequence of a human being, along with a near-complete catalogue of 20,000-odd genes, and a map showing where each gene located on our 22 pairs of autosomes and pigeon-paired sex chromosomes. [ + ]

Patrys (ASX:PAB) has completed the share purchase plan component of a capital raising worth $2.85 million. The clinical stage biopharmaceutical company fell just shy of hitting the maximum target for the capital raising of $2.9 million. [ + ]

New approaches to cancer treatment and improved nickel mining output were the winning ideas from the Grand Final of UniQuest’s annual Trailblazer innovative ideas competition, held at The University of Queensland (UQ) on 4 September 2012. [ + ]

Australian drug developer CBio has completed its merger with US-based Inverseon and formally changed its name to Invion (ASX:IVX). [ + ]

Starpharma's (ASX:SPL) cancer drug development platform has attracted the attention of UK pharmaceutical giant AstraZeneca. [ + ]

After being cleared to submit existing trial data to back up its IND application for pain formulation MoxDuo IR, QRxPharma (ASX:QRX) now expects the US FDA to make its decision in mid-2013. [ + ]

pSivida (ASX:PVA) licensee Alimera has scored a win in efforts to gain UK acceptance for the Iluvien micro-insert as a treatment for chronic diabetic macular edema (DME). [ + ]

AusBiotech has announced it will hold its annual general meeting at the AusBiotech 2012 national conference in Melbourne on Thursday 1 November 2012 at 1:00pm, where business will include the outcome of the election for two directors to join the AusBiotech Board. [ + ]

It has taken nearly a decade of hard work, but the first pages of an ‘Encyclopaedia Genomica’ have been published by an international consortium of researchers, revealing some surprising insights about the human genome. [ + ]

The NSW government has launched a seven-figure fund to encourage the development and commercialisation of innovative medical devices in the state. [ + ]

Avita Medical (ASX:AVH) will raise up to $10m through a placement and SPP to support marketing and US commercialisation efforts for its ReCell Spray-On Skin technology. [ + ]

The best young Australian scientists will have the chance to be mentored by Nobel Prize winners, thanks to a new collaboration between the Australian Academy of Science and the Science and Industry Endowment Fund. [ + ]

The event, to be held in Melbourne – 30 October - 2 November 2012 – will feature expert speakers from overseas and Australia, who will speak on investment, public policy, industry experiences and business development. [ + ]

New Zealand's Innate Immunotherapeutics has launched a US$10 million ($9.75 million) capital raising to help fund an Australian trial of a prospective treatment for progressed multiple sclerosis. [ + ]

Azure Healthcare (ASX:AZV), shed of its unprofitable audio visual business, swung to a $744,000 net profit for FY12. [ + ]